Companies · Biotechnology

JUVA LIFE INC./Canada

Vancouver · Biotechnology

Diligence memoA one-page analyst read on JUVA LIFE INC./Canada — recommendation, valuation, rhythm, risks.→
$208K
Total raised · real
1
Rounds
—
Latest step-up
Top 97%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Thu Feb 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

JUVA LIFE INC./Canada looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.50× the median modeled value of Pre-Seed Biotechnology companies in 2019–2021 (156 peers) — value vs value, same stage and era.
Dormant
  • Last raise 5.4 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

JUVA LIFE INC./Canada is one of 4293 Biotechnology companies tracked from Vancouver. By capital raised it ranks in the long tail (ahead of 4% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2021-02-18
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5M$5.0M$7.5M$10MPre-Seed · 2021-02-18 Raised $208K (real) Modeled valuation $7.7M (est)$208K$7.7MPre-Seed2021

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$208K · 2021

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$7.7M
Base estimate est.
$111K
Conservative case
$72.3M
Upside case
$1.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seed — a round under $1.0M). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
24%
Survival probability
10% low · 44% high
1.86×/yr
Annual markup
2.52×/yr upside case
5.4 yr
Elapsed time used
5.4 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
—
Avg between rounds
—
Capital velocity
5.6 yr
On record since
2021
First round
1
Rounds on file
How it compares to the market

Benchmarked against 4293 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)▼ 0.0× of median
This company$208K
Sector median$7.2M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage)▼ 0.5× of median
This company$208K
Sector median$412K
Modeled value — vs sector median (estimate, all stages)▼ 0.1× of median
This company$7.7M
Sector median$64.2M

Raised more than 4% of sector peers (real $). Modeled value above 15% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #120 of 156.

This companyCohort peer
$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Crimson BioPharm Inc. · Pre-Seed Raised $1.0M · modeled $55.2M (est)Pinpoint Therapeutics Inc. · Pre-Seed Raised $1.0M · modeled $55.2M (est)Transplant Logistics & Informatics Llc · Pre-Seed Raised $1.0M · modeled $55.2M (est)RNAissance AG LLC · Pre-Seed Raised $990K · modeled $54.7M (est)Pylum Biosciences, Inc. · Pre-Seed Raised $990K · modeled $54.7M (est)NanoTomer, Inc. · Pre-Seed Raised $950K · modeled $52.4M (est)Morphogenyx Inc · Pre-Seed Raised $4.0M · modeled $51.0M (est)Ntxbio, Llc · Pre-Seed Raised $1.9M · modeled $50.5M (est)Oncospace, Inc. · Pre-Seed Raised $900K · modeled $49.7M (est)Cerflux, Inc. · Pre-Seed Raised $880K · modeled $48.6M (est)KDx Diagnostics, Inc. · Pre-Seed Raised $1.7M · modeled $45.3M (est)Sensorygen, Inc. · Pre-Seed Raised $814K · modeled $44.9M (est)JUVA LIFE INC./Canada (this company) Raised $208K · modeled $7.7M (est)JUVA LIFE INC./Canada
CompanyStageRaised · realValue · estvs peer med.
Crimson BioPharm Inc.Pre-Seed$1.0M$55.2M3.54×
Pinpoint Therapeutics Inc.Pre-Seed$1.0M$55.2M3.54×
Transplant Logistics & Informatics LlcPre-Seed$1.0M$55.2M3.54×
RNAissance AG LLCPre-Seed$990K$54.7M3.51×
Pylum Biosciences, Inc.Pre-Seed$990K$54.7M3.51×
NanoTomer, Inc.Pre-Seed$950K$52.4M3.36×
Morphogenyx IncPre-Seed$4.0M$51.0M3.27×
Ntxbio, LlcPre-Seed$1.9M$50.5M3.24×
Oncospace, Inc.Pre-Seed$900K$49.7M3.19×
Cerflux, Inc.Pre-Seed$880K$48.6M3.12×
KDx Diagnostics, Inc.Pre-Seed$1.7M$45.3M2.90×
Sensorygen, Inc.Pre-Seed$814K$44.9M2.88×
JUVA LIFE INC./Canada this companyPre-Seed$208K$7.7M0.50×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$208K2021-02-18$1.2M$7.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$208K2021-02-18
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
Intelligence
—
Modeled next raise
$332K
Modeled next size est.range $216K–$531K
—
Last step-up
—
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Mathew Lee—5 other2021-02
Rakesh Patel—4 other2021-02
Douglas Chloupek—1 other2021-02
Kari Gothie——2021-02
Neil Ruditsky——2021-02
Thomas Leschak——2021-02
Registry & provenance

JUVA LIFE INC./Canada is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1778651
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Creative Medical Technologies, Inc.BiotechnologyPre-Seed$200K$5.5Msame sector · same stage
Live Fully, Inc.BiotechnologyPre-Seed$200K$5.1Msame sector · same stage
Noetic Labs Inc.BiotechnologyPre-Seed$200K$8.5Msame sector · same stage
Pana Bio, Inc.BiotechnologyPre-Seed$200K$4.9Msame sector · same stage
CytoImage Inc.BiotechnologyPre-Seed$225K$6.8Msame sector · same stage
NovaVive Inc.BiotechnologyPre-Seed$225K$6.9Msame sector · same stage
MyGenetics LLCBiotechnologyPre-Seed$190K$10.5Msame sector · same stage
CRRI Holdings, IncBiotechnologyPre-Seed$188K$10.4Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Juva Life, Inc.PharmaceuticalsSeries A$168.8M86%
BioVaxys Technology Corp.BiotechnologyPre-Seed$7.2M85%
Juvenescence LtdBiotechnologySeries C$324.6M85%
CancerVAX, Inc.BiotechnologyPre-Seed$7.2M85%
SynLife, Inc.BiotechnologyPre-Seed$38.6M84%
Inspired Life Medical, Inc.BiotechnologySeed$127.4M84%
Love Lifesciences LLCBiotechnologyPre-Seed$3.5M84%
AbiliLife, Inc.BiotechnologyPre-Seed$6.6M84%
Frequently asked
How much funding has JUVA LIFE INC./Canada raised?
JUVA LIFE INC./Canada has raised approximately $208K in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is JUVA LIFE INC./Canada's estimated valuation?
Provath's modeled valuation for JUVA LIFE INC./Canada is approximately $7.7M (modeled range $111K–$72.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is JUVA LIFE INC./Canada at?
JUVA LIFE INC./Canada's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Thu Feb 18.
What does JUVA LIFE INC./Canada do and where is it based?
JUVA LIFE INC./Canada operates in the Biotechnology sector, based in Vancouver.
Explore related

See where JUVA LIFE INC./Canada sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at JUVA LIFE INC./Canada, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.